🔴 First Tracks Biotherapeutics is trading 5.32% down today as rising yields and oil pressure growth stocks

First Tracks Biotherapeutics is trading 5.32% lower at $34.71, with the decline appearing mainly tied to broader risk-off trading rather than a fresh company-specific announcement on September 24, 2026.

• Treasury yields reached 5.14%, oil climbed above $105, and higher-for-longer rate expectations pressured growth assets. Bloomberg reported renewed selling across stocks and bonds.
• Biotechnology stocks fell 2.04%; the prior session’s 10.65% decline suggests continued weakness.